Prof. Haval Shirwan received his Ph.D. in Molecular Biology/Biochemistry from the University of California in 1987. He completed postdoctoral training as a Research Fellow at the California Institute of Technology in 1989 and continued as a Senior Research Fellow at the same institute in 1990. Prof. Shirwan is currently the Director of the Division of Pediatric Research and Associate Director of the Immunomodulation and Regenerative Medicine Program at the Ellis Fischel Cancer Center. He is an elected National Academy of Inventors member,  a NextGen Precision Health Investigator, and a Professor of Pediatrics. His research focuses on developing immunomodulatory approaches for transplantation, autoimmunity, and cancer, using the ProtEx™ platform to generate recombinant immune ligands and exploring various delivery methods.